Geneos Wealth Management’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $747K | Sell |
15,502
-491
| -3% | -$22.9K | 0.02% | 579 |
|
|
2025
Q4 | $775K | Buy |
15,993
+1,924
| +14% | +$95.4K | 0.02% | 561 |
|
|
2025
Q3 | $664K | Sell |
14,069
-1,869
| -12% | -$90.2K | 0.02% | 580 |
|
|
2025
Q2 | $770K | Sell |
15,938
-10,847
| -40% | -$554K | 0.02% | 595 |
|
|
2025
Q1 | $1.49M | Buy |
26,785
+16,562
| +162% | +$896K | 0.02% | 557 |
|
|
2024
Q4 | $493K | Sell |
10,223
-219
| -2% | -$11.1K | 0.02% | 595 |
|
|
2024
Q3 | $602K | Buy |
10,442
+2,014
| +24% | +$109K | 0.02% | 511 |
|
|
2024
Q2 | $409K | Buy |
8,428
+1,365
| +19% | +$65.8K | 0.02% | 544 |
|
|
2024
Q1 | $343K | Buy |
7,063
+582
| +9% | +$28.4K | 0.02% | 572 |
|
|
2023
Q4 | $322K | Buy |
6,481
+1,902
| +42% | +$93K | 0.02% | 561 |
|
|
2023
Q3 | $246K | Buy |
4,579
+124
| +3% | +$6.61K | 0.01% | 630 |
|
|
2023
Q2 | $240K | Buy |
4,455
+936
| +27% | +$50.4K | 0.01% | 639 |
|
|
2023
Q1 | $192K | Sell |
3,519
-397
| -10% | -$19.3K | 0.01% | 659 |
|
|
2022
Q4 | $190K | Sell |
3,916
-368
| -9% | -$16.2K | 0.01% | 635 |
|
|
2022
Q3 | $162K | Sell |
4,284
-1,901
| -31% | -$84.7K | 0.01% | 662 |
|
|
2022
Q2 | $315K | Buy |
6,185
+24
| +0.4% | +$1.27K | 0.02% | 614 |
|
|
2022
Q1 | $316K | Sell |
6,161
-151
| -2% | -$7.8K | 0.01% | 650 |
|
|
2021
Q4 | $316K | Buy |
6,312
+91
| +1% | +$4.5K | 0.01% | 718 |
|
|
2021
Q3 | $298K | Buy |
6,221
+141
| +2% | +$7.17K | 0.01% | 716 |
|
|
2021
Q2 | $318K | Buy |
6,080
+106
| +2% | +$5.53K | 0.01% | 671 |
|
|
2021
Q1 | $312K | Sell |
5,974
-9
| -0.2% | -$432 | 0.01% | 781 |
|
|
2020
Q4 | $293K | Buy |
5,983
+312
| +6% | +$15.4K | 0.01% | 697 |
|
|
2020
Q3 | $287K | Buy |
5,671
+92
| +2% | +$4.74K | 0.01% | 572 |
|
|
2020
Q2 | $284K | Buy |
5,579
+541
| +11% | +$26.3K | 0.02% | 563 |
|
|
2020
Q1 | $213K | Buy |
5,038
+1,813
| +56% | +$86.7K | 0.01% | 592 |
|
|
2019
Q4 | $164K | Buy |
3,225
+544
| +20% | +$25.5K | 0.01% | 772 |
|
|
2019
Q3 | $124K | Buy |
2,681
+40
| +2% | +$1.73K | 0.01% | 820 |
|
|
2019
Q2 | $117K | Buy |
2,641
+116
| +5% | +$4.93K | 0.01% | 850 |
|
|
2019
Q1 | $111K | Buy |
2,525
+516
| +26% | +$22.1K | 0.01% | 828 |
|
|
2018
Q4 | $86K | Sell |
2,009
-183
| -8% | -$8.07K | 0.01% | 889 |
|
|
2018
Q3 | $97K | Sell |
2,192
-1,585
| -42% | -$67.7K | 0.01% | 894 |
|
|
2018
Q2 | $151K | Sell |
3,777
-87
| -2% | -$3.42K | 0.01% | 649 |
|
|
2018
Q1 | $154K | Buy |
3,864
+159
| +4% | +$6.62K | 0.01% | 610 |
|
|
2017
Q4 | $159K | Buy |
3,705
+204
| +6% | +$9.41K | 0.01% | 600 |
|
|
2017
Q3 | $174K | Buy |
3,501
+909
| +35% | +$44K | 0.02% | 552 |
|
|
2017
Q2 | $124K | Buy |
2,592
+456
| +21% | +$21.8K | 0.01% | 627 |
|
|
2017
Q1 | $96K | Sell |
2,136
-485
| -19% | -$20.6K | 0.01% | 672 |
|
|
2016
Q4 | $106K | Buy |
2,621
+39
| +2% | +$1.54K | 0.01% | 603 |
|
|
2016
Q3 | $98K | Sell |
2,582
-99
| -4% | -$3.97K | 0.01% | 606 |
|
|
2016
Q2 | $112K | Sell |
2,681
-138
| -5% | -$5.66K | 0.02% | 563 |
|
|
2016
Q1 | $113K | Buy |
+2,819
| New | +$113K | 0.02% | 550 |
|
Other funds holding SNY
MIP
Geneos Wealth Management's SNY Position: Q1 2026 in Review
Geneos Wealth Management reduced its Sanofi (SNY) stake by 3.1% in Q1 2026, selling an estimated $22.9K and leaving 15,502 shares worth $747K. The position accounts for 0.02% of the portfolio, ranked #579.
Geneos Wealth Management first reported a position in SNY in Q1 2016 and has held it in 41 quarters since. The position peaked at $1.49M in Q1 2025. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.
- Geneos Wealth Management held 15,502 shares of Sanofi worth $747K as of Q1 2026.
- Geneos Wealth Management sold 491 Sanofi shares in Q1 2026, an estimated $22.9K.
- Sanofi made up 0.02% of Geneos Wealth Management's portfolio in Q1 2026, its #579 holding.
- Geneos Wealth Management first reported a position in Sanofi in Q1 2016 and has held it in 41 quarters since.
- Geneos Wealth Management's Sanofi position peaked at $1.49M in Q1 2025.
- 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.
Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.